Trial intelligence / Profile preview

Comparative Effectiveness of Two Versus Three Doses of Hepatitis A Vaccine in Kidney Transplant Recipients

TCTR20180325001Phase 4Recruiting

Sponsor
Faculty of Medicine, Chulalongkorn University
Start
Jul 2016
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4 trial of Hepatitis A virus vaccine in hepatitis A (HAV) (2 arms), sponsored by Faculty of Medicine, Chulalongkorn University. Started Jul 2016; status: recruiting.

02

Drugs

Hepatitis A virus vaccine
03

Conditions

hepatitis A (HAV)

Beyond the preview

Go deeper on TCTR20180325001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180325001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call